HomeCompareRPHM vs MO

RPHM vs MO: Dividend Comparison 2026

RPHM yields 10.99% · MO yields 9.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHM wins by $13.7K in total portfolio value
10 years
RPHM
RPHM
● Live price
10.99%
Share price
$18.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$2,186.89
Full RPHM calculator →
MO
Altria Group Inc.
● Live price
9.11%
Share price
$44.80
Annual div
$4.08
5Y div CAGR
4.3%
Payout ratio
78%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.7K
Annual income
$4,052.72
Full MO calculator →

Portfolio growth — RPHM vs MO

📍 RPHM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHMMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHM + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHM pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHM
Annual income on $10K today (after 15% tax)
$934.07/yr
After 10yr DRIP, annual income (after tax)
$1,858.86/yr
MO
Annual income on $10K today (after 15% tax)
$774.11/yr
After 10yr DRIP, annual income (after tax)
$3,444.81/yr
At 15% tax rate, MO beats the other by $1,585.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHM + MO for your $10,000?

RPHM: 50%MO: 50%
100% MO50/50100% RPHM
Portfolio after 10yr
$34.5K
Annual income
$3,119.80/yr
Blended yield
9.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

RPHM
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-0.1
Piotroski
3/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
+36.7% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHM buys
0
MO buys
0
No recent congressional trades found for RPHM or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHMMO
Forward yield10.99%9.11%
Annual dividend / share$2.00$4.08
Payout ratio50%78%
1-year div growth0%4.1%
5-year div CAGR0%4.3%
Portfolio after 10y$41.3K$27.7K
Annual income after 10y$2,186.89$4,052.72
Total dividends collected$16.4K$20.9K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: RPHM vs MO ($10,000, DRIP)

YearRPHM PortfolioRPHM Income/yrMO PortfolioMO Income/yrGap
1← crossover$11,799$1,098.90$10,740$949.88+$1.1KRPHM
2$13,837$1,211.76$11,601$1,086.84+$2.2KRPHM
3$16,133$1,328.07$12,608$1,250.75+$3.5KRPHM
4$18,710$1,447.20$13,792$1,448.20+$4.9KRPHM
5$21,588$1,568.52$15,190$1,687.69+$6.4KRPHM
6$24,791$1,691.42$16,851$1,980.28+$7.9KRPHM
7$28,341$1,815.27$18,838$2,340.48+$9.5KRPHM
8$32,264$1,939.50$21,230$2,787.44+$11.0KRPHM
9$36,587$2,063.54$24,130$3,346.72+$12.5KRPHM
10$41,334$2,186.89$27,676$4,052.72+$13.7KRPHM

RPHM vs MO: Complete Analysis 2026

RPHMStock

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full RPHM Calculator →

MOConsumer Staples

Altria is a Dividend King with 54+ consecutive years of dividend increases — one of the longest streaks in American corporate history. While cigarette volumes decline, pricing power and new product categories (oral nicotine pouches via NJOY) support cash flows. The near-9% yield is among the highest in the S&P 500.

Full MO Calculator →
📬

Get this RPHM vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHM vs SCHDRPHM vs JEPIRPHM vs ORPHM vs KORPHM vs MAINRPHM vs PMRPHM vs BTIRPHM vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.